Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cadherin related family member 17, pseudogene (CDHR17P) is a non-protein-coding element in the human genome, related to the cadherin-17 gene family. Classified as a pseudogene, it originates from duplication or mutation events that rendered it incapable of producing a functional protein. While some pseudogenes may have gene-regulatory functions or may be transcribed as RNA, the specific functional role (if any) of CDHR17P is not established, and it is not a candidate for drug targeting or biomarker development. CDHR17P is a pseudogene and does not encode a traditional therapeutic target. It is not used for drug development or clinical biomarker purposes, and there is no evidence it plays an active role in disease or physiological pathways relevant for therapy.
None. No drugs are known to act on CDHR17P.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cadherin related family member 17, pseudogene (CDHR17P).